Medical Director/Senior Medical Director, Clinical Development
Agios Pharmaceuticals Inc
Summary
Agios Pharmaceuticals is searching for a dynamic Medical Director / Senior Medical Director to join our clinical development team. The Medical Director/Senior Medical Director is responsible for the development and execution of clinical research and development programs for Agios including the leadership of the pivotal trials, NDA and/or filing activities. This role gives strategic medical and tactical input to the Business Development team. This position serves as a key liaison between company and clinical investigators and establishes credible relationships with opinion leaders, and regulatory officials.
Job description
What you will do:
- Direct involvement in trial design of Phase I/II/III targeting rare or orphan diseases.
- Provide on-going support for open-label extension periods and life cycle management of a product.
- Directly supervise and monitor trial conduct as well as work closely with external medical monitor physicians to assure consistency of conduct across trials.
- Work closely with all functions of the organization and external partners to manage trial execution.
- Provide medical input to global regulatory plans and regulatory meetings in partnership with regulatory affairs.
- Provide medical input to global safety leads and at safety meetings in partnership with safety and medical safety and risk management teams.
- Follow important developments and relevant trends in scientific literature and develop/maintain contracts with external experts to support understanding of the candidate drug effects and to gain strategic insights to the further development and placement of study and overall program.
- Develop effective relationships with clinical research organizations to ensure successful medical oversight of outsourced studies.
- Provide clinical assessments during disease/target evaluation, prioritization and selection, identifying novel therapeutics opportunities as well as critical study design and execution challenges.
- Support qualifications of pharmacodynamic/disease markers of assessment of efficacy.
- Work closely with the project management representative(s) to track trial status.
- Work closely with study physicians, as well as other project team members/functional areas to ensure regulatory compliance.
- Author and review clinical study reports, manuscripts, regulatory documents and other written material related to clinical study.
- Be responsible for the scientific quality of all clinical work.
- Ensure consistent practices with the highest ethical standards in compliance with internal SOPs, local regulations and laws.
What you bring:
- M.D. or equivalent degree
- Board Certification, Board Eligibility or specialist accreditation in internal medicine or pediatrics; specific experience with classical hematologic diseases is desirable.
- 3-10 years in industry (biotech/pharma) specifically within Clinical Development or closely related functions
- Clinical and managerial experience within pharmaceutical trial design and conduct (POC through Phase 3 experience) within the pharmaceutical industry CRO or Academia is required.
- Experience with trials though NDA preferred, but not required
- Excellent interpersonal and public speaking skills are required for this high visibility position.
Requirements
- M.D. or equivalent degree
- Board Certification, Board Eligibility or specialist accreditation in internal medicine or pediatrics
- 3-10 years in industry (biotech/pharma) specifically within Clinical Development or closely related functions
- Clinical and managerial experience within pharmaceutical trial design and conduct (POC through Phase 3 experience) within the pharmaceutical industry CRO or Academia
- Experience with trials through NDA preferred
- Excellent interpersonal and public speaking skills
Benefits
- Premium benefits package
- Performance-based compensation
- Short-term incentives
- Long-term incentives
- Professional development
Company overview
Agios Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, that specializes in developing innovative therapies for rare genetic diseases, with a particular focus on hemolytic anemias. Founded in 2008, the company has established itself as a leader in cellular metabolism research and pyruvate kinase (PK) activation. Agios markets PYRUKYND® (mitapivat), the first FDA-approved disease-modifying therapy for adults with pyruvate kinase deficiency, a rare, lifelong hemolytic anemia. The company's pipeline includes advanced clinical programs targeting thalassemia, sickle cell disease, pediatric PK deficiency, and other rare hematologic disorders. With approximately 486 employees, Agios combines deep biological expertise with real-world insights to advance a growing portfolio of medicines that address significant unmet medical needs in rare disease communities. The company's approach emphasizes strong partnerships with patient communities and healthcare professionals to develop transformative treatments that improve patient outcomes and quality of life.